106931-79-7

Basic information

• Product Name: 4-BENZYLOXY-3-CHLORO-BENZOIC ACID
• Synonyms: 4-BENZYLOXY-3-CHLORO-BENZOIC ACID;RARECHEM AL BE 0478
• CAS NO: 106931-79-7
• Molecular Formula: C₁₄H₁₁ClO₃
• Molecular Weight: 262.69
• Product Categories: pharmacetical
• Mol File: 106931-79-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-BENZYLOXY-3-CHLORO-BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZYLOXY-3-CHLORO-BENZOIC ACID(106931-79-7)
• EPA Substance Registry System: 4-BENZYLOXY-3-CHLORO-BENZOIC ACID(106931-79-7)

Safety Data

• Hazardous Substances Data: 106931-79-7(Hazardous Substances Data)

Upstream product

• 3964-58-7 3-chloro-4-hydroxybenzoic acid 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 7732-18-5 water 
• 159465-83-5 benzyl 4-(benzyloxy)-3-chlorobenzoate 
• 536974-86-4 4-benzyloxy-3-chloro-benzoic acid methyl ester 

Downstream Products

• 123436-73-7 4-benzyloxy-3-chlorobenzoic acid chloride 

Relevant articles and documents

MULTICYCLIC COMPOUNDS AND METHODS OF USING SAME

The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of

SUBSTITUTED 4-BENZYLOXY-BENZOIC ACID AMIDE DERIVATIVES

The present invention relates to novel substituted 4-benzyloxy-benzoic acid amide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor overactivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).

AMIDE DERIVATIVES BEARING A CYCLOPROPYLAMINOACARBONYL SUBSTITUENT USEFUL AS CYTO KINE INHIBITORS

The invention concerns a compound of the Formula (I), wherein Qa is heteroaryl and is substituted with halogeno; R1 and R2 are each hydrogen; and Qb is phenyl or heteroaryl, and Qb may optionally bear 1 or 2 substituents selected from hydroxy, halogeno and (1-6C)alkyl, or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical condions mediated by cytokines.

A four-step synthesis of erythro-m-chloro-3-hydroxytyrosine ethyl ester enantiomerically pure

Pure erythro-m-chloro-3-hydroxytyrosine having the (2R,3R) configuration, a residue of Vancomycin and Aridicin A, has been prepared in 4 steps using an aldol addition involving a directly generated titanium enolate derived from a chiral iminoglycinate. (+)-Hydroxypinanone was used as a recoverable chiral auxiliary. The (2S,3S)-erythro isomer will be, of course, available from (-)-hydroxypinanone.

Anthracene derivatives

An anthracene derivative having at least two groups of the formula: STR1 wherein R1 and R2 are independently hydrogen, alkyl, alkoxy, etc., is particular effective for forming an antireflection coating for preventing multiple reflection of exposing light from a highly reflective substrate, etc.

Deep ultraviolet absorbent and its use in pattern formation

A deep ultraviolet absorbent comprising at least one compound having one or more glycidyl groups in the molecule and at least one anthracene derivative, and a solvent capable of dissolving these compounds is effective for preventing reflection of deep ultraviolet light from a substrate during formation of resist pattern, resulting in forming ultra-fine patterns without causing notching and halation.